top of page

Sale of Secondary Common Shares in KRY International AB

Stadsholmen Equity

7 Aug 2023

Stadsholmen Equity is proud to have acted as equity broker in several secondary transactions in the health tech company Kry. We would like to thank the parties involved in the transactions for their confidence in us, and we look forward to following the future journey of the company.

Kry, founded in 2014, is Europe's leading digital-first healthcare provider. The company digitize the patient meeting to improve accessibility and quality of healthcare.


With its foundation in digital, the company has recently expanded its offer also to include physical care, in order to be a provider throughout the entire patient journey. In mid-2022, Kry reached the milestone of 8 million patient consultations, and today they have over 5,000 medical doctors, nurses and psychologists as well as +50 physical health care centres contributing to the turnover of SEK ~2.4bn.


Like many of its peers, Kry has been focusing on profitability over growth for some time, with a 20 percentage points improved group EBITDA margin over the past two quarters. The Nordic operations have been profitable since Q1(23), and the company is working towards profitability in France — where they have also achieved a milestone of over 1 million patient consultations since their launch in 2018. Despite tightening measures to focus on profitability, the company has surpassed their goal in terms of number of registered patients.

Stadsholmen_Equity_Logo_White.png

Stadsholmen Equity AB is responsible for the information on this website. While all reasonable care has been taken to ensure that the information is true and not misleading, Stadsholmen Equity AB does not guarantee its accuracy or completeness. Stadsholmen Equity AB or any of its directors may have a position, or otherwise be interested in, transactions in securities that are directly or indirectly the subject of this website. This website is constructed for general information only. Investors should seek financial advice regarding the appropriateness of investing in any securities or investment strategies discussed on this website and should understand that statements regarding future prospects may not be realised. Investments in early-stage companies involve very high risk and past performance is not necessarily indicative of future performance. Stadsholmen Equity AB accepts no liability whatsoever for any direct or consequential loss. This website is produced for informational purposes only and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of any offer to buy any securities.

​

Privacy Policy | Cookie Policy

 © 2025 Stadsholmen Equity AB. All Rights Reserved.

Company Registration Number 559397-1111

bottom of page